India’s exports worth more than $30 billion to the United States continue to remain largely insulated from higher tariffs imposed under the US Section 301 trade measures, providing significant relief to the country’s export sector. Several of India’s major export categories—including pharmaceuticals, gems and jewellery, engineering goods, textiles, chemicals and select industrial products—have so far avoided the steeper duties that affect imports from certain countries.
The continued exemption of these products has helped Indian exporters maintain their competitiveness in the US market despite an increasingly protectionist global trade environment. The US remains India’s largest export destination, accounting for a substantial share of the country’s merchandise exports.
Trade experts note that the tariff relief strengthens India’s position as a preferred sourcing destination, particularly as global companies continue to diversify supply chains. The advantage has become more significant amid shifting manufacturing bases and ongoing efforts by multinational firms to reduce dependence on single-country sourcing.
Industry stakeholders, however, caution that exporters should continue to monitor developments in US trade policy, as tariff structures and product coverage under Section 301 remain subject to periodic reviews. Maintaining compliance with US import regulations and enhancing product competitiveness will remain essential for sustaining export growth.
The continued protection of India’s key exports from higher Section 301 duties is expected to support bilateral trade momentum and provide stability for exporters targeting the lucrative US market.